LBT Innovations (ASX:LBT) EV-to-EBIT : -0.94 (As of May. 31, 2024)

View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, LBT Innovations's Enterprise Value is A$17.08 Mil. LBT Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.10 Mil. Therefore, LBT Innovations's EV-to-EBIT for today is -0.94.

The historical rank and industry rank for LBT Innovations's EV-to-EBIT or its related term are showing as below:

ASX:LBT' s EV-to-EBIT Range Over the Past 10 Years
Min: -64.69 Med: -1.97 Max: 71.63
Current: -0.95

During the past 13 years, the highest EV-to-EBIT of LBT Innovations was 71.63. The lowest was -64.69. And the median was -1.97.

ASX:LBT's EV-to-EBIT is ranked worse than
100% of 449 companies
in the Medical Devices & Instruments industry
Industry Median: 19.76 vs ASX:LBT: -0.95

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. LBT Innovations's Enterprise Value for the quarter that ended in Dec. 2023 was A$12.16 Mil. LBT Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.10 Mil. LBT Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -148.78%.

LBT Innovations EV-to-EBIT Historical Data

The historical data trend for LBT Innovations's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations EV-to-EBIT Chart

LBT Innovations Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

-3.24

-6.98

-1.83

-3.06

-0.58

LBT Innovations Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-	-3.06	-	-0.58	-

Competitive Comparison of LBT Innovations's EV-to-EBIT

For the Medical Devices subindustry, LBT Innovations's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LBT Innovations's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LBT Innovations's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LBT Innovations's EV-to-EBIT falls into.

LBT Innovations EV-to-EBIT Calculation

LBT Innovations's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	17.080	/	-18.097
	=	-0.94

LBT Innovations's current Enterprise Value is A$17.08 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LBT Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.10 Mil.

LBT Innovations (ASX:LBT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

LBT Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-18.097	/	12.16348
	=	-148.78 %

LBT Innovations's Enterprise Value for the quarter that ended in Dec. 2023 was A$12.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LBT Innovations's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-18.10 Mil.

LBT Innovations EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of LBT Innovations's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Anster Street, Adelaide, SA, AUS, 5000

Website

https://www.lbtinnovations.com

LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines